Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

 

 

Volume: 26S4 - September 2000

Expert Working Group on HHV-6 and 7 Laboratory Diagnosis and Testing


March 7-8, 2000

Canadian Science Centre for Human and Animal Health
Winnipeg, Canada

Bureau of Microbiology*
Bureau of Infectious Diseases**
Reference Laboratory Capacity Program for Infectious Disease Surveillance
Laboratory Centre for Disease Control***
Health Canada

Health Canada re-alignment:
* Laboratory for Human and Animal Health
** Centre for Infectious Disease Prevention and Control
*** Public Health Agency of Canada

Adobe Downloadable Document PDF (173 KB)


Table of Contents

Introduction

Recommendations

Overview

  • Properties of HHV-6/7 and overview of the clinical spectrum of disease (Pellett)

Laboratory

  • Methods Overview of current HHV-6/7 diagnostic methods (Tipples)
  • Standardization and QA/QC issues in laboratory virology (Campione-Piccardo)

International Research

  • HHV-6 and 7 serology: comparison of epidemiologic findings from different countries and different assays (Cermelli and Jacobson)
  • HHV-6 and multiple sclerosis (Jacobson)

Research in Canada

  • HHV-6 in kidney transplantation (Acott and Lee)
  • HHV-6, HHV-7 and CMV plasma viremia in bone marrow transplant recipients (Diaz-Mitoma)
  • Diagnosis and management of HHV-6 infection among bone marrow transplant recipients in Toronto (Allen)
  • HHV-6 in patients who are heterophile antibody negative with atypical lymphocytes and/or lymphocytosis (Doyle)
  • HHV-6 in the pediatric setting (Thomas)
  • Multiplex assay for semi-quantitative detection and distinction of human ß-herpesviruses: Prevalence during HIV infection and multiple sclerosis (Sahai)
  • HHV-6 studies at the Central Laboratory of the Ontario Ministry of Health (George)
  • HHV-6 testing at the Provincial Laboratory of Public Health for Southern Alberta (Fonseca)
  • Pediatric Investigators Collaborative Network on Infections in Canada (Embree)

Surveillance of the Blood Supply

  • Surveillance for bloodborne pathogens in Canada (Giulivi)

Appendix 1: Participant List


This publication was produced by the Document Dissemination Division, Public Health Agency of Canada, Health Canada.

To obtain additional copies or subscribe to the Canada Communicable Disease Report, please contact the Member Service Centre, Canadian Medical Association, 1867 Alta Vista Drive, Ottawa ON, Canada K1G 3Y6. Tel.: (613) 731-8610, ext. 2307; 888-855-2555 (toll free in Canada and U.S.) or by FAX: (613) 236-8864.

This publication can also be accessed electronically via Internet using a Web browser at http://www.hc-sc.gc.ca/hpb/lcdc

[Table of Contents] [Next]

Last Updated: 2002-11-08 Top